Distribution, metabolism, and excretion of a novel surface-active agent, purified poloxamer 188, in rats, dogs, and humans

被引:99
作者
Grindel, JM
Jaworski, T
Piraner, O
Emanuele, RM
Balasubramanian, M
机构
[1] CytRx Corp, Norcross, GA 30092 USA
[2] PPD Dev, Morrisville, NC USA
[3] Ctr Dis Control, Atlanta, GA 30341 USA
[4] Innoconcepts, Roswell, GA 30075 USA
关键词
surfactant; renal clearance; species comparison; disposition;
D O I
10.1002/jps.10190
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Purified poloxamer 188 (PP188) is a nonionic, block copolymer surfactant with hemorheologic, antithrombotic, and anti-adhesive properties. PP188 is being studied in phase III clinical trials in sickle cell disease and has been found to be well tolerated and has demonstrated benefit in ameliorating the effects of acute painful vasoocclusive crisis. The disposition of PP188 was studied in rats, dogs, and humans to establish a basis for understanding the safety parameters in support of clinical trials. PP188 was primarily distributed in extracellular water with little or no uptake by red blood cells, and had its highest concentrations in highly perfused tissues such as the kidney, liver, spleen, lymph nodes, and gastrointestinal tract. PP188 had no apparent effect on P450 isozymes in vitro. Metabolism was limited (<5% of dose) with a higher molecular weight copolymer being the only other material detected in plasma or urine. Renal clearance was the controlling route of clearance for PP188 from the body. The 48-h intravenous infusion doses of PP188 were cleared in all species by approximately 1 week after the cessation of dose administration. PP188's disposition is a model for other nonionic block copolymers with similar physical and chemical properties. (C) 2002 Wiley-Liss, Inc.
引用
收藏
页码:1936 / 1947
页数:12
相关论文
共 25 条
[1]   RheothRx (poloxamer 188) injection for the acute painful episode of sickle cell disease: A pilot study [J].
AdamsGraves, P ;
Kedar, A ;
Koshy, M ;
Steinberg, M ;
Veith, R ;
Ward, D ;
Crawford, R ;
Edwards, S ;
Bustrack, J ;
Emanuele, M .
BLOOD, 1997, 90 (05) :2041-2046
[2]   INHIBITION OF RED BLOOD CELL-INDUCED PLATELET-AGGREGATION IN WHOLE-BLOOD BY A NONIONIC SURFACTANT, POLOXAMER 188 (RHEOTHRX(R) INJECTION) [J].
ARMSTRONG, JK ;
MEISELMAN, HJ ;
FISHER, TC .
THROMBOSIS RESEARCH, 1995, 79 (5-6) :437-450
[3]   PURIFICATION OF PLURONIC F-68 FOR PERFLUOROCHEMICAL EMULSIFICATION [J].
BENTLEY, PK ;
DAVIS, SS ;
JOHNSON, OL ;
LOWE, KC ;
WASHINGTON, C .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1989, 41 (09) :661-663
[4]  
CARR ME, 1991, THROMB HAEMOSTASIS, V66, P565
[5]  
CARTER C, 1992, CLIN HEMORHEOL, V12, P109
[6]   DEVELOPMENT AND PRELIMINARY APPLICATION OF A SIMPLE ASSAY OF S-MEPHENYTOIN 4-HYDROXYLASE ACTIVITY IN HUMAN LIVER-MICROSOMES [J].
CHIBA, K ;
MANABE, K ;
KOBAYASHI, K ;
TAKAYAMA, Y ;
TANI, M ;
ISHIZAKI, T .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1993, 44 (06) :559-562
[7]   Plasma membrane ordering agent pluronic F-68 (PF-68) reduces neurotransmitter uptake and release and produces learning and memory deficits in rats [J].
Clarke, MSF ;
Prendergast, MA ;
Terry, AV .
LEARNING & MEMORY, 1999, 6 (06) :634-649
[8]   DETERMINATION OF PARA-NITROPHENOL HYDROXYLASE-ACTIVITY OF RAT-LIVER MICROSOMES BY HIGH-PRESSURE LIQUID-CHROMATOGRAPHY [J].
DUESCHER, RJ ;
ELFARRA, AA .
ANALYTICAL BIOCHEMISTRY, 1993, 212 (02) :311-314
[9]  
Files BA, 1998, BLOOD, V92, p30B
[10]  
GROVER FL, 1973, ARCH SURG-CHICAGO, V106, P307